{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-025702","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.028634+00:00","generated_at":"2026-05-17T09:40:54.765998+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Qualigen restructures $4.45M Marizyme note, secures assets, pro forma equity positive","bullets":["Amended Note principal $4,451,462 with 18% interest, due Aug 21, 2026; includes $216K new advance.","Marizyme granted security interest in substantially all assets under new Security Agreement.","Pro forma balance sheet shows cash $4.59M, total equity $3.24M; company reports equity > $2.5M.","Forbearance on demand for 365 days; default rate increases 5% per annum."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-025702","json":"https://secwatch.observer/filing/0001641172-25-025702.json","markdown":"https://secwatch.observer/filing/0001641172-25-025702.md","text":"https://secwatch.observer/filing/0001641172-25-025702.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/0001641172-25-025702-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:40:54.765998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f38c58935e05be0e4a0c9c62694b30f57e06ecd","claim":"AIxCrypto Holdings, Inc. amended loan of $4,451,462.18 with Marizyme, Inc. at 18% per annum maturing August 21, 2026.","evidence_excerpt":"The Amended Note has a principal balance of $4,451,462.18, which represents (i) the outstanding balance of the Prior Note, (ii) accrued and unpaid interest thereon, and (iii) an additional advance of $216,000 made by the Company to Marizyme on the date of the Amended Note. The Amended Note bears interest at a rate of 18% per annum, with all accrued interest and the full principal balance due in a single balloon payment on August 21, 2026 (subject to earlier demand upon an event of default).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/0001641172-25-025702-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$4,451,462.18"},{"label":"Counterparty","value":"Marizyme, Inc."},{"label":"Rate","value":"18% per annum"},{"label":"Maturity","value":"August 21, 2026"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}